59 results
6-K
EX-99.1
IMRN
Immuron Limited
23 Apr 24
Report of Foreign Private Issuer
6:06am
. Clostridioides Difficile 2H 2022 1H 2023 2H 2023 1H 2024
9 IMMURON’S CLINICAL PROGRAMS – OPPORTUNITY ASSESSMENT › Immuron’s development of IMM - 124E … C m o a r n p i o ty ra * te Opportunity Assessment for IMM - 124E › Infectious disease experts reacted favorably to the IMM - 529 MOA, and its
6-K
EX-99.1
IMRN
Immuron Limited
15 Apr 24
Report of Foreign Private Issuer
8:00am
, the traveler’s diarrhea treatment market is large and growing at a CAGR of ~7%. According to a Lumanity Opportunity Assessment for IMM-124E, based
6-K
EX-99.1
IMRN
Immuron Limited
14 Mar 24
Report of Foreign Private Issuer
6:50am
uptake. Lu m C o a r n p i t o y r a O t p e po r tu ni t y Assessment for IMM - 529 Market Phase III Phase II Phase I Indication Compound or brand name … to GlobalData For personal use only L u C m o a r n p i o t y r a * t e Op p ortuni t y Assessment for IMM - 124E
8 NEAR TERM MILESTONES ANTICIPATED
6-K
EX-99.1
IMRN
Immuron Limited
21 Feb 24
Report of Foreign Private Issuer
8:00am
(ETEC) strains known to cause Travelers’ diarrhea » Approved by performing a risk assessment for use in food - producing animals with the Australian
6-K
EX-99.1
IMRN
Immuron Limited
28 Nov 23
Investor Webinar Presentation
6:17am
efficacy goals could broaden use. Lumanity* Opportunity Assessment for IMM - 124E Corporate › Infectious disease experts reacted favorably to the IMM - 529 … lead to higher uptake. Lumanity Opportunity Assessment for IMM - 529 Market Phase III Phase II Phase I Indication Compound or brand name Traveler’s
6-K
EX-99.1
02n59372uvx2
21 Nov 23
Report of Foreign Private Issuer
6:05am
6-K
EX-99.1
pykj3d mhyz1d12
30 Oct 23
Immuron CEO, Steven Lydeamore to present at AusBioInvest
8:00am
6-K
EX-99.1
u6r31 0caeiavv
3 Oct 23
Report of Foreign Private Issuer
9:31pm
6-K
EX-99.1
c4uw74n8vsfwbv2ugle
28 Sep 23
Report of Foreign Private Issuer
8:43am
6-K
EX-99.1
ts9h 2qd5ij
11 Sep 23
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
6:10am
6-K
EX-99.1
inbglbsxpxrxv o2p
22 Jun 23
Report of Foreign Private Issuer
6:03am
6-K
EX-99.1
tn80qz
7 Jun 23
Immuron CEO, Steven Lydeamore presents at LD Micro
8:00am
6-K
EX-99.1
g3i0h 9mzwpl7yweeue5
2 May 23
Report of Foreign Private Issuer
6:04am
6-K
EX-99.1
m4owz5g9trqo
19 Apr 23
Q3 FY23 Business Update Presentation
6:06am
6-K
EX-99.1
zw1 vjwrsdgh1thm
21 Nov 22
Report of Foreign Private Issuer
6:02am
6-K
EX-99.1
ga27r i84babsn
26 Oct 22
Report of Foreign Private Issuer
6:10am
6-K
EX-99.2
mdiqwgwjg m7
31 Aug 22
Preliminary Final Report
7:50am
6-K
EX-99.1
s22yz
31 Aug 22
Preliminary Final Report
7:50am